“Serum Adiponectin as a Diagnostic Marker of Early Renal Dysfunction in Patients with Hypertension and Type 2 Diabetes”, joms, vol. 21, no. 1, pp. 22–28, Jun. 2026, doi: 10.51984/18dd9796.